Agilon Health, Inc. (AGL) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-1013.5%

-$797.59

vs $87.31 price

Levered DCF

-$485.02

After debt service

Piotroski score

3 / 9

Weak

Altman Z-score

2.2

Grey zone

Rating

C-

Overall 1 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
P/E	-0.7×	-3.02×	-19.61×	-62.08×	-24.77×	-193.75×	-41.89×
P/B	2.25×	1.66×	7.75×	6.33×	9.22×	-41.9×	-51.31×
P/S	0.05×	0.13×	1.19×	2.76×	6.62×	9.79×	14.99×
EV / EBITDA	-0.4×	-2.89×	-30.24×	-85.27×	-25.06×	-296.6×	-184.7×
Gross margin	-3.2%	0.1%	1.6%	4.7%	4.3%	7.7%	3.6%
Operating margin	-7.1%	-4.8%	-5.4%	-4.4%	-24.5%	-4.7%	-13.4%
Net margin	-6.8%	-4.3%	-6.1%	-4.5%	-26.7%	-4.9%	-35.6%
Current ratio	1.02×	1.27×	1.51×	2.71×	3.83×	1.1×	1.23×
Debt / equity	0.29×	0.09×	0.08×	0.05×	0.05×	-0.26×	-0.34×
Interest coverage	-63.41×	-47.29×	-34.87×	-23.5×	-60.57×	-6.97×	-11.75×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Return on equity	-319.8%	-55.2%	-39.7%	-10.2%	-37.2%	21.1%	121.8%
Return on invested capital	-196.7%	-50.0%	-30.0%	-9.0%	-30.1%	-31.0%	-51.6%
Return on assets	-31.9%	-15.0%	-15.1%	-6.3%	-25.6%	-13.5%	-70.2%
Free cash flow yield	-41.7%	-9.1%	-3.6%	-2.5%	-1.6%	-0.5%	-0.9%
Earnings yield	-142.2%	-33.3%	-5.1%	-1.6%	-4.0%	-0.5%	-2.4%
Enterprise value	$148.2M	$630.9M	$5.1B	$6.2B	$9.1B	$11.9B	$11.9B
Net debt / EBITDA	0.37×	0.69×	0.37×	5.7×	2.75×	0.84×	0.71×
Cash conversion cycle (days)	-22	-8	-4	-1	-17	-41	-47